Navigation Links
Caliper Life Sciences' Second Quarter 2009 Financial Results Conference Call Notice
Date:7/16/2009

HOPKINTON, Mass., July 16 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) will conduct a conference call discussing the company's second quarter 2009 financial results at 9:00 a.m. ET on Thursday, July 30. Kevin Hrusovsky, President and Chief Executive Officer and Peter McAree, Chief Financial Officer, will host the call. Management will discuss operational and financial results and the company's outlook for the future.

A news release discussing Caliper's second quarter 2009 financial results will be issued Thursday, July 30 at approximately 7:00 a.m. ET.

Participants please call 888.713.4209 five to ten minutes prior to the call and use the participant passcode of 64195782. International callers can access the call by dialing 617.213.4863 and entering the same passcode. You may also pre-register for the call at https://www.theconferencingservice.com/prereg/key.process?key=PB3C889QD.

A live webcast of the call can be accessed at www.fulldisclosure.com or on the Caliper website at www.caliperLS.com in the Events section of the Investor Relations page. A webcast replay of the call will remain available until Caliper's earnings call for the third quarter of 2009.

Telephone replays of the conference call will be available approximately two hours after the completion of the call. To access a telephone playback of the proceedings from July 30 through August 6, dial 888-286-8010 and use the participant passcode of 38849510. International callers can access the playback by dialing 617-801-6888 and using the same participant passcode.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis
2. Caliper Life Sciences to Webcast Investor Session of Open House
3. Caliper Life Sciences Reports First Quarter 2009 Results
4. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
5. EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort
6. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
7. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
8. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
9. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
10. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
11. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com News ... ... conditions are being pressured as of late due to the ... pain management has a dramatic impact on patient,s quality of ... development activities for identifying new forms of opioid formulations that ...
(Date:3/22/2017)... 22, 2017   VWR (NASDAQ: ... product and service solutions to laboratory and ... acquired EPL Archives, Inc., an international biorepository ... entire regulated product research, development and commercialization ... and ancillary services. EPL Archives is widely ...
(Date:3/22/2017)... ... March 21, 2017 , ... Proper glycosylation is critical for ... increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, there is a ... , To meet this demand, the team at SCIEX has developed a ...
(Date:3/22/2017)... ... March 21, 2017 , ... The Conference Forum has ... Summit) to be held on May 10-11, 2017, at the Colonnade Hotel in Boston, ... for Chief Medical Officer peer-to-peer learning, benchmarking and support. , “The Chief Medical Officer ...
Breaking Biology Technology:
(Date:3/6/2017)... Calif. , March 6, 2017 ... and sales technology, today announced Predictive Sales Coach ... for infusing actionable sales intelligence into Salesforce. This ... automatically enable their sales organizations with deep knowledge ... that allow for intelligent engagement. Predictive Sales Coach ...
(Date:3/1/2017)...  Aware, Inc. (NASDAQ: AWRE), a leading supplier of ... Moberg has resigned, effective March 3, 2017, as ... and Treasurer of Aware citing a desire to retire.  ... of the Board of Directors of Aware. ... and co-President, General Counsel has been named Chief Executive ...
(Date:2/26/2017)...  Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring, announces the appointment of ... "Too often, too many offenders return to jail ... trying to tackle this ongoing problem and improve ... members. While significant steps are underway, Securus continues to ...
Breaking Biology News(10 mins):